On May 1, 2024, Pfizer Inc., a pharmaceutical giant, announced its financial results for the first quarter of 2024. The announcement was made through a press release which is now furnished as Exhibit 99 and incorporated by reference. Pfizer, listed on the New York Stock Exchange under the ticker PFE, has made this information available in accordance with the requirements of the Securities Exchange Act of 1934. The details of the financial results were not disclosed in the announcement. However, the press release is expected to provide a comprehensive overview of the company's financial performance during the quarter. Pfizer's common stock and 1.000% Notes due 2027 are both traded on the New York Stock Exchange. The company has confirmed that the information provided in the press release, including the financial results, is not to be considered 'filed' for regulatory purposes and is not incorporated by reference into any of their other filings, unless explicitly stated.

On May 1, 2024, Pfizer Inc., a pharmaceutical giant, announced its financial results for the first quarter of 2024. The announcement was made through a press release which is now furnished as Exhibit 99 and incorporated by reference. Pfizer, listed on the New York Stock Exchange under the ticker PFE, has made this information available in accordance with the requirements of the Securities Exchange Act of 1934. The details of the financial results were not disclosed in the announcement. However, the press release is expected to provide a comprehensive overview of the company's financial performance during the quarter. Pfizer's common stock and 1.000% Notes due 2027 are both traded on the New York Stock Exchange. The company has confirmed that the information provided in the press release, including the financial results, is not to be considered 'filed' for regulatory purposes and is not incorporated by reference into any of their other filings, unless explicitly stated.